AVITA Medical, Inc. (AVH.AX)
AUD 2.87
(-3.69%)
AUD 2.87
(-3.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -26.04 Million USD | 22.45% |
| 2021 | -33.58 Million USD | -26.63% |
| 2020 | -26.52 Million USD | 36.13% |
| 2019 | -41.52 Million USD | -67.97% |
| 2018 | -24.72 Million AUD | -88.26% |
| 2017 | -13.13 Million AUD | -34.8% |
| 2016 | -9.74 Million AUD | -16.03% |
| 2015 | -8.39 Million AUD | -37.9% |
| 2014 | -6.08 Million AUD | 2.5% |
| 2013 | -6.24 Million AUD | 16.01% |
| 2012 | -7.43 Million AUD | -40.15% |
| 2011 | -5.3 Million AUD | -36.23% |
| 2010 | -3.89 Million AUD | -87.47% |
| 2009 | -2.07 Million AUD | 41.79% |
| 2008 | -3.56 Million AUD | 13.91% |
| 2007 | -4.14 Million AUD | -12.33% |
| 2006 | -3.69 Million AUD | 56.31% |
| 2005 | -8.44 Million AUD | 0.0% |
| 2003 | -4.27 Million AUD | -206.49% |
| 2002 | -1.39 Million AUD | -256.96% |
| 2001 | -390.44 Thousand AUD | -167.81% |
| 2000 | 575.83 Thousand AUD | 60.11% |
| 1999 | 359.64 Thousand AUD | -38.31% |
| 1998 | 582.96 Thousand AUD | 125.46% |
| 1997 | -2.28 Million AUD | -620.17% |
| 1996 | 440.17 Thousand AUD | 134.22% |
| 1995 | -1.28 Million AUD | 42.44% |
| 1994 | -2.23 Million AUD | -1310.09% |
| 1993 | -158.48 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -10.36 Million USD | -14.51% |
| 2023 Q3 | -8.52 Million USD | 17.72% |
| 2023 Q1 | -9.05 Million USD | -74.29% |
| 2022 Q2 | -6.11 Million USD | 35.34% |
| 2022 Q4 | -5.19 Million USD | 4.54% |
| 2022 Q3 | -5.44 Million USD | 11.05% |
| 2022 Q1 | -9.45 Million USD | -11.91% |
| 2022 FY | - USD | 22.45% |
| 2021 FY | - USD | -26.63% |
| 2021 Q1 | -5.98 Million USD | -9.5% |
| 2021 Q2 | -4.7 Million USD | 21.42% |
| 2021 Q3 | -5.93 Million USD | -26.18% |
| 2021 Q4 | -8.45 Million USD | -42.46% |
| 2020 Q2 | -12.9 Million USD | 14.23% |
| 2020 FY | - USD | 36.13% |
| 2020 Q1 | -15.04 Million USD | -43.36% |
| 2020 Q3 | -9.99 Million USD | 22.5% |
| 2020 Q4 | -5.46 Million USD | 45.34% |
| 2019 Q1 | -10.1 Million USD | -29.58% |
| 2019 Q2 | -10.16 Million USD | -0.58% |
| 2019 Q4 | -10.49 Million USD | -200.75% |
| 2019 Q3 | -3.48 Million USD | 65.67% |
| 2019 FY | - USD | -67.97% |
| 2018 Q4 | -7.79 Million USD | 0.0% |
| 2018 FY | - AUD | -88.26% |
| 2018 Q3 | -7.79 Million USD | -28.67% |
| 2018 Q2 | -6.06 Million USD | -14.33% |
| 2018 Q1 | -5.3 Million USD | -47.15% |
| 2017 Q1 | -3.99 Million USD | -73.54% |
| 2017 Q4 | -3.6 Million USD | 0.0% |
| 2017 FY | - AUD | -34.8% |
| 2017 Q3 | -3.6 Million USD | 9.45% |
| 2017 Q2 | -3.97 Million USD | 0.35% |
| 2016 Q4 | -2.3 Million USD | 0.0% |
| 2016 FY | - AUD | -16.03% |
| 2016 Q2 | -3.03 Million USD | 0.17% |
| 2016 Q3 | -2.3 Million USD | 24.3% |
| 2016 Q1 | -3.04 Million USD | -17.02% |
| 2015 Q1 | -2.48 Million USD | -33.69% |
| 2015 Q2 | -2.48 Million USD | -0.01% |
| 2015 Q4 | -2.6 Million USD | 0.0% |
| 2015 Q3 | -2.6 Million USD | -4.77% |
| 2015 FY | - AUD | -37.9% |
| 2014 Q2 | -1.67 Million USD | -0.88% |
| 2014 FY | - AUD | 2.5% |
| 2014 Q4 | -1.85 Million USD | 0.0% |
| 2014 Q3 | -1.85 Million USD | -10.82% |
| 2014 Q1 | -1.66 Million USD | 1.58% |
| 2013 Q1 | -2.29 Million USD | -16.97% |
| 2013 FY | - AUD | 16.01% |
| 2013 Q4 | -1.68 Million USD | 0.0% |
| 2013 Q3 | -1.68 Million USD | 26.44% |
| 2013 Q2 | -2.29 Million USD | 0.0% |
| 2012 Q3 | -1.96 Million USD | -10.5% |
| 2012 Q1 | -1.77 Million USD | 0.0% |
| 2012 Q4 | -1.96 Million USD | 0.0% |
| 2012 Q2 | -1.77 Million USD | 0.0% |
| 2012 FY | - AUD | -40.15% |
| 2011 FY | - AUD | -36.23% |
| 2010 FY | - AUD | -87.47% |
| 2009 FY | - AUD | 41.79% |
| 2008 FY | - AUD | 13.91% |
| 2007 FY | - AUD | -12.33% |
| 2006 FY | - AUD | 56.31% |
| 2005 FY | - AUD | 0.0% |
| 2003 FY | - AUD | -206.49% |
| 2002 FY | - AUD | -256.96% |
| 2001 FY | - AUD | -167.81% |
| 2000 FY | - AUD | 60.11% |
| 1999 FY | - AUD | -38.31% |
| 1998 FY | - AUD | 125.46% |
| 1997 FY | - AUD | -620.17% |
| 1996 FY | - AUD | 134.22% |
| 1995 FY | - AUD | 42.44% |
| 1994 FY | - AUD | -1310.09% |
| 1993 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 27.787% |
| Adherium Limited | -11.56 Million AUD | -125.216% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -253.868% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -380.226% |
| Anteris Technologies Ltd | -66.9 Million AUD | 61.071% |
| Control Bionics Limited | -5.15 Million AUD | -404.924% |
| CardieX Limited | -6.71 Million AUD | -288.045% |
| Compumedics Limited | 2.78 Million AUD | 1033.847% |
| Cochlear Limited | 579.5 Million AUD | 104.494% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -645.89% |
| Cyclopharm Limited | -3.03 Million AUD | -758.183% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -1145.452% |
| Nova Eye Medical Limited | -5.97 Million AUD | -335.608% |
| HeraMED Limited | -3.97 Million AUD | -555.705% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | -19.088% |
| ImpediMed Limited | -22.05 Million AUD | -18.113% |
| InhaleRx Limited | -1.41 Million AUD | -1742.273% |
| LBT Innovations Limited | -4.04 Million AUD | -543.245% |
| Micro-X Limited | -14.35 Million AUD | -81.486% |
| Neurotech International Limited | -8.24 Million AUD | -215.925% |
| OncoSil Medical Limited | -11.97 Million AUD | -117.474% |
| PolyNovo Limited | 5.17 Million AUD | 603.772% |
| Respiri Limited | -7.04 Million AUD | -269.437% |
| SomnoMed Limited | -2.32 Million AUD | -1018.477% |
| Universal Biosensors, Inc. | -9.09 Million AUD | -186.51% |
| Uscom Limited | -1.5 Million AUD | -1625.623% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -429.65% |